Distribution of cardiovascular disease and retinopathy in patients with type 2 diabetes according to different classification systems for chronic kidney disease: A cross-sectional analysis of the renal insufficiency and cardiovascular events (RIACE) Italian multicenter study

Cardiovascular Diabetology

Volumn 13, Issue 1, 2014, Pages

  Pugliese, Giuseppe ^a,k,l,m   Solini, Anna ^b,k,l,v   Bonora, Enzo ^c,k,s   Orsi, Emanuela ^d,k   Zerbini, Gianpaolo ^e,l   Fondelli, Cecilia ^f,w   Gruden, Gabriella ^g,l,n   Cavalot, Franco ^g,o   Lamacchia, Olga ^h,z   Trevisan, Roberto ^i,k,l,r   Vedovato, Monica ^j,t   Penno, Giuseppe ^b,k,l,u   Laviola, Luigi ^k,l,aa   Nicolucci, Antonio ^k   Cosmo, Salvatore De ^l   Morano, Susanna ^l,x   Pugliese, Francesco ^l   Salvi, Laura ^m   Bollanti, Lucilla ^m   Bazuro, Alessandra ^m   Cavallo Perin, Paolo ⁿ   Lorenzati, Bartolomeo ⁿ   Trovati, Mariella ^o   Anfossi, Giovanni ^o   Chirio, Massimo ^o   Martina, Valentina ^e   Maestroni, Silvia ^e   Montefusco, Laura ^d   Zimbalatti, Dario ^d   Pontiroli, Antonio ^p   Veronelli, Annamaria ^p   Zecchini, Barbara ^p   Arosio, Maura ^q   Dolci, Alessia ^q   Corsi, Anna ^r   Zoppini, Giacomo ^s   Avogaro, Angelo ^t   Pagnin, Elisa ^t   Pucci, Laura ^u   Lucchesi, Daniela ^u   Russo, Eleonora ^u   Garofolo, Monia ^u   Dotta, Francesco ^w   Nigi, Laura ^w   Gatti, Alessandra ^x   Buzzetti, Raffaella ^y   Foffi, Chiara ^y   Cignarelli, Mauro ^z   Pinnelli, Sabina ^z   Monaco, Lucia ^z   Giorgino, Francesco ^aa   Perrini, Sebastio ^aa   Sesti, Giorgio ^ab   Andreozzi, Francesco ^ab   Baroni, Marco Giorgio ^ac   Frau, Giuseppina ^ac   more..

^a SAPIENZA UNIVERSITY OF ROME   (Italy)

^b UNIVERSITY OF PISA   (Italy)

^c UNIVERSITY OF VERONA   (Italy)

^d FONDAZIONE IRCCS CA GRANDA OSPEDALE MAGGIORE POLICLINICO   (Italy)

^e SAN RAFFAELE HOSPITAL   (Italy)

^f UNIVERSITY OF SIENA   (Italy)

^g UNIVERSITY OF TURIN   (Italy)

^h UNIVERSITY OF FOGGIA   (Italy)

ⁱ Hospital of Bergamo   (Italy)

^j UNIVERSITY OF PADOVA   (Italy)

^k Department of Clinical and Experimental Medicine University of Padua ^*  (Italy)

^l SID   (Italy)

^m Azienda Ospedaliera Sant'Andrea   (Romania)

ⁿ MOLINETTE HOSPITAL   (Italy)

^o SAN LUIGI GONZAGA HOSPITAL   (Italy)

^p Ospedale San Paolo   (Italy)

^q San Giuseppe Hospital   (Italy)

^r OSPEDALI RIUNITI   (Italy)

^s MAGGIORE HOSPITAL   (Italy)

^t UNIVERSITY HOSPITAL OF PADOVA   (Italy)

^u UNIVERSITY HOSPITAL OF PISA   (Italy)

^v UNIVERSITY OF PISA   (Italy)

^w UNIVERSITY HOSPITAL OF SIENA   (Italy)

^x Policlinico Umberto I   (Romania)

^y SANTA MARIA GORETTI HOSPITAL   (Italy)

^z OSPEDALI RIUNITI   (Italy)

^aa POLICLINICO   (Italy)

^ab Policlinico Mater Domini   (Italy)

^ac Policlinico Universitario Monserrato   (Italy)

more..

Author keywords

Albuminuria; Cardiovascular disease; Chronic kidney disease; Classification; Diabetic retinopathy; eGFR

Indexed keywords

ANTIHYPERTENSIVE AGENT; ANTILIPEMIC AGENT; CREATININE; GLUCOSE; HEMOGLOBIN A1C; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; INSULIN; LOW DENSITY LIPOPROTEIN CHOLESTEROL; TRIACYLGLYCEROL;

ALBUMINURIA; ARTICLE; CARDIOVASCULAR DISEASE; CHRONIC KIDNEY DISEASE; CREATININE BLOOD LEVEL; CROSS-SECTIONAL STUDY; DIABETIC RETINOPATHY; DISEASE CLASSIFICATION; DISEASE DURATION; DISEASE SEVERITY; DYSLIPIDEMIA; FEMALE; GLOMERULUS FILTRATION RATE; HUMAN; IMMUNONEPHELOMETRY; IMMUNOTURBIDIMETRY; ITALY; KIDNEY FAILURE; KIDNEY FUNCTION TEST; MACROALBUMINURIA; MAJOR CLINICAL STUDY; MALE; MEDICAL HISTORY; MULTICENTER STUDY (TOPIC); NON INSULIN DEPENDENT DIABETES MELLITUS; OPHTHALMOSCOPY; PREVALENCE; STRUCTURED INTERVIEW; WAIST CIRCUMFERENCE;

AGED; AGED, 80 AND OVER; CARDIOVASCULAR DISEASES; COHORT STUDIES; CROSS-SECTIONAL STUDIES; DIABETES MELLITUS, TYPE 2; DIABETIC RETINOPATHY; FEMALE; HUMANS; ITALY; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; RENAL INSUFFICIENCY; RENAL INSUFFICIENCY, CHRONIC;

EID: 84899557970     PISSN: None     EISSN: 14752840     Source Type: Journal    
DOI: 10.1186/1475-2840-13-59     Document Type: Article

References (31)

1. Levey AS, Coresh J, Balk E, Kausz AT, Levin A, Steffes MW, Hogg RJ, Perrone RD, Lau J, Eknoyan G. National Kidney Foundation: National Kidney Foundation practice guidelines for chronic kidney disease: evaluation, classification, and stratification. Ann Intern Med 2003, 139:137-147. 10.7326/0003-4819-139-2-200307150-00013, 12859163.
2. Glassock RJ, Winearls C. Screening for CKD with eGFR: doubts and dangers. Clin J Am Soc Nephrol 2008, 3:1563-1568. 10.2215/CJN.00960208, 18667744.
3. Glassock RJ, Winearls C. An epidemic of chronic kidney disease: fact or fiction?. Nephrol Dial Transplant 2008, 23:1117-1121.
4. Coresh J, Selvin E, Stevens LA, Manzi J, Kusek JW, Eggers P, Van Lente F, Levey AS. Prevalence of chronic kidney disease in the United States. JAMA 2007, 298:2038-2047. 10.1001/jama.298.17.2038, 17986697.
5. Thomas MC, Macisaac RJ, Jerums G, Weekes A, Moran J, Shaw JE, Atkins RC. Nonalbuminuric renal impairment in type 2 diabetic patients and in the general population (national evaluation of the frequency of renal impairment cO-existing with NIDDM [NEFRON] 11). Diabetes Care 2009, 32:1497-1502. 10.2337/dc08-2186, 2713618, 19470839.
6. Molitch ME, Steffes M, Sun W, Rutledge B, Cleary P, de Boer IH, Zinman B, Lachin J, Epidemiology of Diabetes Interventions and Complications Study Group Development and progression of renal insufficiency with and without albuminuria in adults with type 1 diabetes in the diabetes control and complications trial and the epidemiology of diabetes interventions and complications study. Diabetes Care 2010, 33:1536-1543. 10.2337/dc09-1098, 2890355, 20413518, Epidemiology of Diabetes Interventions and Complications Study Group.
7. Retnakaran R, Cull CA, Thorne KI, Adler AI, Holman RR, UKPDS Study Group Risk factors for renal dysfunction in type 2 diabetes: U.K. prospective diabetes study 74. Diabetes 2006, 55:1832-1839. 10.2337/db05-1620, 16731850, UKPDS Study Group.
8. Penno G, Solini A, Bonora E, Fondelli C, Orsi E, Zerbini G, Trevisan R, Vedovato M, Gruden G, Cavalot F, Cignarelli M, Laviola L, Morano S, Nicolucci A, Pugliese G, For the Renal Insufficiency And Cardiovascular Events (RIACE) Study Group Clinical significance of nonalbuminuric renal impairment in type 2 diabetes. J Hypertens 2011, 29:1802-1809. 10.1097/HJH.0b013e3283495cd6, 21738053, For the Renal Insufficiency And Cardiovascular Events (RIACE) Study Group.
9. Ninomiya T, Perkovic V, de Galan BE, Zoungas S, Pillai A, Jardine M, Patel A, Cass A, Neal B, Poulter N, Mogensen CE, Cooper M, Marre M, Williams B, Hamet P, Mancia G, Woodward M, Macmahon S, Chalmers J, ADVANCE Collaborative Group Albuminuria and kidney function independently predict cardiovascular and renal outcomes in diabetes. J Am Soc Nephrol 2009, 20:1813-1821. 10.1681/ASN.2008121270, 2723977, 19443635, ADVANCE Collaborative Group.
10. Drury PL, Ting R, Zannino D, Ehnholm C, Flack J, Whiting M, Fassett R, Ansquer JC, Dixon P, Davis TM, Pardy C, Colman P, Keech A. Estimated glomerular filtration rate and albuminuria are independent predictors of cardiovascular events and death in type 2 diabetes mellitus: the fenofibrate intervention and event lowering in diabetes (FIELD) study. Diabetologia 2011, 54:32-43. 10.1007/s00125-010-1854-1, 20668832.
11. McIsaac RJ, Jerums G. Diabetic kidney disease with and without albuminuria. Curr Opin Nephrol Hypertens 2011, 20:246-257. 10.1097/MNH.0b013e3283456546, 21422923.
12. Brantsma AH, Bakker SJ, Hillege HL, de Zeeuw D, de Jong PE, Gansevoort RT, PREVEND Study Group Cardiovascular and renal outcome in subjects with K/DOQI stage 1-3 chronic kidney disease: the importance of urinary albumin excretion. Nephrol Dial Transplant 2008, 23:3851-3858. 10.1093/ndt/gfn356, 18641082, PREVEND Study Group.
13. Hemmelgarn BR, Manns BJ, Lloyd A, James MT, Klarenbach S, Quinn RR, Wiebe N, Tonelli M, Alberta Kidney Disease Network Relation between kidney function, proteinuria, and adverse outcomes. JAMA 2010, 303:423-429. 10.1001/jama.2010.39, 20124537, Alberta Kidney Disease Network.
14. Gerstein HC, Mann JF, Yi Q, Zinman B, Dinneen SF, Hoogwerf B, Hallé JP, Young J, Rashkow A, Joyce C, Nawaz S, Yusuf S, HOPE Study Investigators Albuminuria and risk of cardiovascular events, death, and heart failure in diabetic and nondiabetic individuals. JAMA 2001, 286:421-426. 10.1001/jama.286.4.421, 11466120, HOPE Study Investigators.
15. Eijkelkamp WB, Zhang Z, Remuzzi G, Parving HH, Cooper ME, Keane WF, Shahinfar S, Gleim GW, Weir MR, Brenner BM, de Zeeuw D. Albuminuria is a target for renoprotective therapy independent from blood pressure in patients with type 2 diabetic nephropathy: post hoc analysis from the reduction of endpoints in NIDDM with the Angiotensin II Antagonist Losartan (RENAAL) Trial. J Am Soc Nephrol 2007, 18:1540-1546. 10.1681/ASN.2006050445, 17409317.
16. Holtkamp FA, de Zeeuw D, de Graeff PA, Laverman GD, Berl T, Remuzzi G, Packham D, Lewis JB, Parving HH, Lambers Heerspink HJ. Albuminuria and blood pressure, independent targets for cardioprotective therapy in patients with diabetes and nephropathy: a post hoc analysis of the combined RENAAL and IDNT trials. Eur Heart J 2011, 32:1493-1499. 10.1093/eurheartj/ehr017, 21421598.
17. Levey AS, de Jong PE, Coresh J, El Nahas M, Astor BC, Matsushita K, Gansevoort RT, Kasiske BL, Eckardt KU. The definition, classification and prognosis of chronic kidney disease: a KDIGO controversies conference report. Kidney Int 2011, 80:17-28. 10.1038/ki.2010.483, 21150873.
18. Tonelli M, Muntner P, Lloyd A, Manns BJ, James MT, Klarenbach S, Quinn RR, Wiebe N, Hemmelgarn BR, Alberta Kidney Disease Network Using proteinuria and estimated glomerular filtration rate to classify risk in patients with chronic kidney disease. A cohort study. Ann Intern Med 2011, 154:12-21. 10.7326/0003-4819-154-1-201101040-00003, 21200034, Alberta Kidney Disease Network.
19. Levey AS, Tangri N, Stevens LA. Classification of chronic kidney disease: a step forward. Ann Intern Med 2011, 154:65-67. 10.7326/0003-4819-154-1-201101040-00012, 21200043.
20. Kidney Disease: Improving Global Outcomes (KDIGO) CKD Work Group KDIGO clinical practice guideline for the evaluation and management of chronic kidney disease. Kidney Int Suppl 2013, 3:1-150. Kidney Disease: Improving Global Outcomes (KDIGO) CKD Work Group.
21. Pugliese G, Solini A, Fondelli C, Trevisan R, Vedovato M, Nicolucci A, Penno G, Renal Insufficiency And Cardiovascular Events (RIACE) Study Group Reproducibility of albuminuria in type 2 diabetic subjects. Findings from the renal insufficiency and cardiovascular events (RIACE) study. Nephrol Dial Transpl 2011, 26:3950-3954. Renal Insufficiency And Cardiovascular Events (RIACE) Study Group.
22. Penno G, Solini A, Bonora E, Fondelli C, Orsi E, Zerbini G, Morano S, Cavalot F, Lamacchia O, Laviola L, Nicolucci A, Pugliese G, Renal Insufficiency And Cardiovascular Events Study Group HbA1c variability as an independent correlate of nephropathy, but not retinopathy, in patients with type 2 diabetes: the renal insufficiency and cardiovascular events (RIACE) Italian multicenter study. Diabetes Care 2013, 36:2301-2310. 10.2337/dc12-2264, 23491522, Renal Insufficiency And Cardiovascular Events Study Group.
23. Levey AS, Bosch JP, Lewis JB, Greene T, Rogers N, Roth D. A more accurate method to estimate glomerular filtration rate from serum creatinine: a new prediction equation. Modification of diet in renal disease study group. Ann Intern Med 1999, 130:461-470. 10.7326/0003-4819-130-6-199903160-00002, 10075613.
24. Wilkinson CP, Ferris FL, Klein RE, Lee PP, Agardh CD, Davis M, Dills D, Kampik A, Pararajasegaram R, Verdaguer JT, Global Diabetic Retinopathy Project Group Proposed international clinical diabetic retinopathy and diabetic macular edema disease severity scales. Ophthalmology 2003, 110:1677-1682. 10.1016/S0161-6420(03)00475-5, 13129861, Global Diabetic Retinopathy Project Group.
25. Penno G, Solini A, Zoppini G, Orsi E, Zerbini G, Trevisan R, Gruden G, Cavalot F, Laviola L, Morano S, Nicolucci A, Pugliese G, Renal Insufficiency And Cardiovascular Events (RIACE) Study Group Rate and determinants of association between advanced retinopathy and chronic kidney disease in patients with type 2 diabetes: the renal insufficiency and cardiovascular events (RIACE) Italian multicenter study. Diabetes Care 2012, 35:2317-2323. 10.2337/dc12-0628, 3476898, 23093684, Renal Insufficiency And Cardiovascular Events (RIACE) Study Group.
26. Solini A, Penno G, Bonora E, Fondelli C, Orsi E, Arosio M, Trevisan R, Vedovato M, Cignarelli M, Andreozzi F, Nicolucci A, Pugliese G, Renal Insufficiency And Cardiovascular Events (RIACE) Study Group Diverging association of reduced glomerular filtration rate and albuminuria with coronary and noncoronary events in patients with type 2 diabetes: the renal insufficiency and cardiovascular events (RIACE) Italian multicentre study. Diabetes Care 2012, 35:143-149. 10.2337/dc11-1380, 3241302, 22124714, Renal Insufficiency And Cardiovascular Events (RIACE) Study Group.
27. Penno G, Solini A, Zoppini G, Orsi E, Fondelli C, Zerbini G, Morano S, Cavalot F, Lamacchia O, Trevisan R, Vedovato M, Pugliese G. Renal insufficiency and cardiovascular events (RIACE) study group. Hemoglobin A1c variability as an independent correlate of cardiovascular disease in patients with type 2 diabetes. A cross-sectional analysis of the renal insufficiency and cardiovascular events (RIACE) Italian multicenter study. Cardiovasc Diabetol 2013, 12:98. 10.1186/1475-2840-12-98, 3750360, 23829205.
28. Inker LA, Tonelli M, Hemmelgarn BR, Levitan EB, Muntner P. Comparison of concurrent complications of CKD by 2 risk categorization systems. Am J Kidney Dis 2012, 59:372-381. 10.1053/j.ajkd.2011.09.021, 3288542, 22113126.
29. Adler AI, Stevens RJ, Manley SE, Bilous RW, Cull CA, Holman RR, UKPDS Group Development and progression of nephropathy in type 2 diabetes: the United Kingdom prospective diabetes study (UKPDS 64). Kidney Int 2003, 63:225-232. 10.1046/j.1523-1755.2003.00712.x, 12472787, UKPDS Group.
30. Almdal T, Scharling H, Jensen JS, Vestergaard H. The independent effect of type 2 diabetes mellitus on ischemic heart disease, stroke, and death: a population-based study of 13,000 men and women with 20 years of follow-up. Arch Intern Med 2004, 164:1422-1426. 10.1001/archinte.164.13.1422, 15249351.
31. Fenwick EK, Pesudovs K, Rees G, Dirani M, Kawasaki R, Wong TY, Lamoureux EL. The impact of diabetic retinopathy: understanding the patient's perspective. Br J Ophthalmol 2011, 95:774-782. 10.1136/bjo.2010.191312, 20940313.